Articles

A multidisciplinary clinic approach is the key to successful treatment of aggressive, locally advanced prostate cancer, according to researchers from the Kimmel Cancer Center (KCC) of Thomas Jefferson University, Philadelphia.
 
Read More ›

Women who are on intravenous (IV) chemotherapy regimens for recurrent ovarian carcinoma are at risk for nonadherence or nonpersistence with their treatment. But telephone support by an advance practice nurse (APN) can lower this risk and even boost compliance, a new, nonrandomized study suggests.
 

Men treated with long-term androgen deprivation therapy (ADT) for prostate cancer are at increased risk for colorectal cancer, according to a study released in the Journal of the National Cancer Institute.
 
Read More ›

Denosumab delayed or prevented skeletal-related events (SREs) better than zoledronic acid, according to a study comparing the two agents in patients with breast cancer and bone metastases.
 
Read More ›

The prognosis for patients with biliary tract cancer is poor, and no standard palliative care has been defined. Now Austrian researchers report that adding cetuximab to gemcitabine and oxaliplatin (GEMOX) for patients with advanced biliary tract cancer results in a high overall response rate and good disease control and is well tolerated.
 
Read More ›

Age is an important factor when considering tamoxifen therapy for older women with early-stage breast cancer, according to a large retrospective study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology. The findings indicate that older women treated with conservative surgery and radiation therapy (CS + RT) derive only limited benefit from tamoxifen.
 
Read More ›

Patients with chronic lymphocytic leukemia (CLL) who have insufficient levels of vitamin D at the time of diagnosis are at greater risk of cancer progression and death than patients with adequate levels, Mayo Clinic researchers have found.
 
Read More ›

A large National Cancer Institute (NCI)–sponsored study has shown for the first time that a screening method can reduce deaths from lung cancer by detecting cancers at relatively early stages.
 

Use of aspirin or other anticoagulants in addition to radiation therapy or surgery may reduce the risk of dying of prostate cancer by more than half, according to a large study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology.
 
Read More ›

Treatment with a combination of hormone therapy and radiation therapy (RT) improves overall and disease-specific survival in men with locally advanced prostate cancer compared with hormone therapy alone, according to interim results of a study presented at the 52nd Annual Meeting of the American Society for Radiation Oncology.
 
Read More ›

Page 359 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: